유전성 질환용 유전자 치료 시장 보고서(2026년)

Gene therapy for inherited genetic disorders is a medical approach that addresses the underlying cause of hereditary diseases by repairing or replacing defective genes. Its primary objective is to offer a potential cure rather than simply managing symptoms. This therapy introduces functional genes into a patient's cells, restores normal cellular function, and improves overall health. It holds significant promise for treating rare genetic disorders, providing the potential for long-lasting or even permanent therapeutic effects.

The main types of gene therapy for inherited genetic disorders include viral vector-based therapies, gene editing techniques, ribonucleic acid (RNA)-based therapies, and ex vivo gene therapy. Viral vector-based therapies employ genetically engineered, non-replicating viruses to deliver therapeutic genetic material into patient cells for disease treatment. These therapies are used in a range of applications, including inherited metabolic disorders, neurological disorders, cardiovascular disorders, musculoskeletal disorders, and ophthalmic disorders, and are utilized by various end users such as hospitals, specialty clinics, research institutes, and others.

Tariffs have impacted the gene therapy for inherited genetic disorders market by increasing costs of imported viral vectors, gene editing reagents, and stem cell therapy components. Segments like viral vector-based therapies and RNA-based therapeutics are most affected, particularly in North America, Europe, and Asia-Pacific regions such as China and India. These tariffs have led to higher therapy costs and potential delays in clinical trials. On the positive side, tariffs have encouraged domestic production, innovation in cost-effective gene therapy techniques, and local R&D investments.

The gene therapy for inherited genetic disorders market research report is one of a series of new reports from The Business Research Company that provides gene therapy for inherited genetic disorders market statistics, including gene therapy for inherited genetic disorders industry global market size, regional shares, competitors with a gene therapy for inherited genetic disorders market share, detailed gene therapy for inherited genetic disorders market segments, market trends and opportunities, and any further data you may need to thrive in the gene therapy for inherited genetic disorders industry. This gene therapy for inherited genetic disorders market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gene therapy for inherited genetic disorders market size has grown rapidly in recent years. It will grow from $4.05 billion in 2025 to $4.84 billion in 2026 at a compound annual growth rate (CAGR) of 19.3%. The growth in the historic period can be attributed to limited availability of advanced gene therapy techniques, reliance on conventional treatments for genetic disorders, increasing prevalence of inherited genetic diseases, early clinical research on viral vectors, rising awareness of rare disease management.

The gene therapy for inherited genetic disorders market size is expected to see rapid growth in the next few years. It will grow to $9.69 billion in 2030 at a compound annual growth rate (CAGR) of 19.0%. The growth in the forecast period can be attributed to development of novel viral vectors and gene editing technologies, expansion of rna-based therapies, increasing adoption of ex vivo stem cell therapies, rising investment in personalized gene therapies, growth in hospital and specialty clinic capabilities for gene therapy administration. Major trends in the forecast period include expansion of viral vector-based therapies for rare genetic disorders, growth in ex vivo gene therapy applications, increasing adoption of rna-based therapeutics, rising focus on treating neurological and ophthalmic disorders, integration of personalized medicine in gene therapy.

The growing demand for personalized medicine is expected to drive the expansion of the gene therapy for inherited genetic disorders market in the coming years. Personalized medicine involves tailoring medical treatment to an individual's genetic profile and personal characteristics to optimize care. Its adoption is increasing due to advancements in genetic technologies, which make it easier and more cost-effective to customize treatments to each patient's unique genetic makeup. Personalized medicine enhances gene therapy by enabling precise gene targeting and delivery, improving treatment efficacy while minimizing side effects. For example, according to the Personalized Medicine Coalition in February 2024, the U.S. Food and Drug Administration (FDA) approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022. These approvals included seven cancer drugs and three therapies for other diseases and conditions. This rising demand for personalized treatments is therefore supporting the growth of the gene therapy for inherited genetic disorders market.

Key companies in this market are focusing on innovative approaches, such as ex vivo CRISPR/Cas9-based gene-edited cell therapies, to meet the demand for potentially curative, one-time treatments that reduce the need for lifelong transfusions, repeated hospitalizations, and high chronic-care costs in inherited blood and metabolic disorders. Ex vivo CRISPR/Cas9 therapy involves harvesting a patient's hematopoietic stem cells, using CRISPR/Cas9 to precisely edit disease-causing genes (or regulatory elements that increase protective fetal hemoglobin), and reinfusing the modified cells to provide long-term therapeutic benefits. For instance, in December 2023, Vertex Pharmaceuticals, a U.S.-based biopharmaceutical company, received FDA approval for CASGEVY (exagamglogene autotemcel), a CRISPR/Cas9-based ex vivo gene-edited cell therapy for sickle cell disease. CASGEVY is derived from a patient's own hematopoietic stem cells, which are edited to increase fetal hemoglobin levels. The therapy features precise genome editing performed ex vivo, a one-time administration, and durable effects. Its primary application is treating severe sickle cell disease, and clinical trials have shown significant reductions in vaso-occlusive crises and transfusion dependence compared with previous standard-of-care treatments.

In October 2024, Ocuphire Pharma Inc., a U.S.-based biotechnology company, acquired Opus Genetics Inc. for an undisclosed sum. Through this acquisition, Ocuphire Pharma aims to strengthen its leadership in developing gene therapies for rare inherited retinal diseases by combining Opus's innovative pipeline with its own development expertise. Opus Genetics Inc. is a U.S.-based biotechnology company specializing in gene therapies for inherited genetic disorders.

Major companies operating in the gene therapy for inherited genetic disorders market are Sanofi S.A., Novartis AG, Astellas Pharma Inc., Vertex Pharmaceuticals Incorporated, Genentech, Biomarin Pharmaceutical Inc, Sarepta Therapeutics Inc., Krystal Biotech Inc., Rocket Pharmaceuticals Inc., Sangamo Therapeutics Inc., REGENXBIO Inc., Passage Bio Inc., Voyager Therapeutics Inc., Generation Bio Co., Avrobio Inc, Editas Medicine Inc., MeiraGTx Holdings Plc, uniQure N.V., Intellia Therapeutics Inc., Bluebird Bio Inc, 4D Molecular Therapeutics Inc., CRISPR Therapeutics AG

North America was the largest region in the gene therapy for inherited genetic disorders market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene therapy for inherited genetic disorders market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gene therapy for inherited genetic disorders market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gene therapy for inherited genetic disorders market consists of revenues earned by entities by providing services such as genetic testing and diagnosis, personalized treatment planning, and gene delivery and administration. The market value includes the value of related goods sold by the service provider or included within the service offering. The gene therapy for inherited genetic disorders market also includes sales of zolgensma, luxturna, and strimvelis. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gene Therapy For Inherited Genetic Disorders Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses gene therapy for inherited genetic disorders market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gene therapy for inherited genetic disorders ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gene therapy for inherited genetic disorders market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Viral Vector-Based Therapies; Gene Editing Techniques; Ribonucleic Acid-Based Therapies; Ex Vivo Gene Therapy
• 2) By Application: Inherited Metabolic Disorders; Neurological Disorders; Cardiovascular Disorders; Musculoskeletal Disorders; Ophthalmic Disorders
• 3) By End-User: Hospitals; Specialty Clinics; Research Institutes; Other End-Users
• Subsegments:
• 1) By Viral Vector-Based Therapies: Adenovirus Vectors; Adeno-Associated Virus (AAV) Vectors; Lentivirus Vectors
• 2) By Gene Editing Techniques: Zinc Finger Nucleases (ZFNs); Transcription Activator-Like Effector Nucleases (TALENs); Meganucleases
• 3) By Ribonucleic Acid-Based Therapies: Small Interfering Ribonucleic Acid; Antisense Oligonucleotides (ASOs); Messenger Ribonucleic Acid (mRNA) Therapies
• 4) By Ex Vivo Gene Therapy: Hematopoietic Stem Cell Gene Therapy; Mesenchymal Stem Cell Gene Therapy; Induced Pluripotent Stem Cell (iPSC) Therapy
• Companies Mentioned: Sanofi S.A.; Novartis AG; Astellas Pharma Inc.; Vertex Pharmaceuticals Incorporated; Genentech; Biomarin Pharmaceutical Inc; Sarepta Therapeutics Inc.; Krystal Biotech Inc.; Rocket Pharmaceuticals Inc.; Sangamo Therapeutics Inc.; REGENXBIO Inc.; Passage Bio Inc.; Voyager Therapeutics Inc.; Generation Bio Co.; Avrobio Inc; Editas Medicine Inc.; MeiraGTx Holdings Plc; uniQure N.V.; Intellia Therapeutics Inc.; Bluebird Bio Inc; 4D Molecular Therapeutics Inc.; CRISPR Therapeutics AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Gene Therapy For Inherited Genetic Disorders Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Gene Therapy For Inherited Genetic Disorders Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Gene Therapy For Inherited Genetic Disorders Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Gene Therapy For Inherited Genetic Disorders Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Artificial Intelligence & Autonomous Intelligence
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Expansion Of Viral Vector-Based Therapies For Rare Genetic Disorders
  • 4.2.2 Growth In Ex Vivo Gene Therapy Applications
  • 4.2.3 Increasing Adoption Of Rna-Based Therapeutics
  • 4.2.4 Rising Focus On Treating Neurological And Ophthalmic Disorders
  • 4.2.5 Integration Of Personalized Medicine In Gene Therapy

5. Gene Therapy For Inherited Genetic Disorders Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Specialty Clinics
• 5.3 Research Institutes
• 5.4 Gene Therapy Centers
• 5.5 Academic And Biotech Research Laboratories

6. Gene Therapy For Inherited Genetic Disorders Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Gene Therapy For Inherited Genetic Disorders Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Gene Therapy For Inherited Genetic Disorders PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Gene Therapy For Inherited Genetic Disorders Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Gene Therapy For Inherited Genetic Disorders Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Gene Therapy For Inherited Genetic Disorders Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Gene Therapy For Inherited Genetic Disorders Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Gene Therapy For Inherited Genetic Disorders Market Segmentation

• 9.1. Global Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Viral Vector-Based Therapies, Gene Editing Techniques, Ribonucleic Acid-Based Therapies, Ex Vivo Gene Therapy
• 9.2. Global Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Inherited Metabolic Disorders, Neurological Disorders, Cardiovascular Disorders, Musculoskeletal Disorders, Ophthalmic Disorders
• 9.3. Global Gene Therapy For Inherited Genetic Disorders Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Specialty Clinics, Research Institutes, Other End-Users
• 9.4. Global Gene Therapy For Inherited Genetic Disorders Market, Sub-Segmentation Of Viral Vector-Based Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Adenovirus Vectors, Adeno-Associated Virus (AAV) Vectors, Lentivirus Vectors
• 9.5. Global Gene Therapy For Inherited Genetic Disorders Market, Sub-Segmentation Of Gene Editing Techniques, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Zinc Finger Nucleases (ZFNs), Transcription Activator-Like Effector Nucleases (TALENs), Meganucleases
• 9.6. Global Gene Therapy For Inherited Genetic Disorders Market, Sub-Segmentation Of Ribonucleic Acid-Based Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Small Interfering Ribonucleic Acid, Antisense Oligonucleotides (ASOs), Messenger Ribonucleic Acid (mRNA) Therapies
• 9.7. Global Gene Therapy For Inherited Genetic Disorders Market, Sub-Segmentation Of Ex Vivo Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hematopoietic Stem Cell Gene Therapy, Mesenchymal Stem Cell Gene Therapy, Induced Pluripotent Stem Cell (iPSC) Therapy

10. Gene Therapy For Inherited Genetic Disorders Market Regional And Country Analysis

• 10.1. Global Gene Therapy For Inherited Genetic Disorders Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Gene Therapy For Inherited Genetic Disorders Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Gene Therapy For Inherited Genetic Disorders Market

• 11.1. Asia-Pacific Gene Therapy For Inherited Genetic Disorders Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Gene Therapy For Inherited Genetic Disorders Market

• 12.1. China Gene Therapy For Inherited Genetic Disorders Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Gene Therapy For Inherited Genetic Disorders Market

• 13.1. India Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Gene Therapy For Inherited Genetic Disorders Market

• 14.1. Japan Gene Therapy For Inherited Genetic Disorders Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Gene Therapy For Inherited Genetic Disorders Market

• 15.1. Australia Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Gene Therapy For Inherited Genetic Disorders Market

• 16.1. Indonesia Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Gene Therapy For Inherited Genetic Disorders Market

• 17.1. South Korea Gene Therapy For Inherited Genetic Disorders Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Gene Therapy For Inherited Genetic Disorders Market

• 18.1. Taiwan Gene Therapy For Inherited Genetic Disorders Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Gene Therapy For Inherited Genetic Disorders Market

• 19.1. South East Asia Gene Therapy For Inherited Genetic Disorders Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Gene Therapy For Inherited Genetic Disorders Market

• 20.1. Western Europe Gene Therapy For Inherited Genetic Disorders Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Gene Therapy For Inherited Genetic Disorders Market

• 21.1. UK Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Gene Therapy For Inherited Genetic Disorders Market

• 22.1. Germany Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Gene Therapy For Inherited Genetic Disorders Market

• 23.1. France Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Gene Therapy For Inherited Genetic Disorders Market

• 24.1. Italy Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Gene Therapy For Inherited Genetic Disorders Market

• 25.1. Spain Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Gene Therapy For Inherited Genetic Disorders Market

• 26.1. Eastern Europe Gene Therapy For Inherited Genetic Disorders Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Gene Therapy For Inherited Genetic Disorders Market

• 27.1. Russia Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Gene Therapy For Inherited Genetic Disorders Market

• 28.1. North America Gene Therapy For Inherited Genetic Disorders Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Gene Therapy For Inherited Genetic Disorders Market

• 29.1. USA Gene Therapy For Inherited Genetic Disorders Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Gene Therapy For Inherited Genetic Disorders Market

• 30.1. Canada Gene Therapy For Inherited Genetic Disorders Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Gene Therapy For Inherited Genetic Disorders Market

• 31.1. South America Gene Therapy For Inherited Genetic Disorders Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Gene Therapy For Inherited Genetic Disorders Market

• 32.1. Brazil Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Gene Therapy For Inherited Genetic Disorders Market

• 33.1. Middle East Gene Therapy For Inherited Genetic Disorders Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Gene Therapy For Inherited Genetic Disorders Market

• 34.1. Africa Gene Therapy For Inherited Genetic Disorders Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Gene Therapy For Inherited Genetic Disorders Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Gene Therapy For Inherited Genetic Disorders Market Regulatory and Investment Landscape

36. Gene Therapy For Inherited Genetic Disorders Market Competitive Landscape And Company Profiles

• 36.1. Gene Therapy For Inherited Genetic Disorders Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Gene Therapy For Inherited Genetic Disorders Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Gene Therapy For Inherited Genetic Disorders Market Company Profiles
  • 36.3.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Vertex Pharmaceuticals Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Genentech Overview, Products and Services, Strategy and Financial Analysis

37. Gene Therapy For Inherited Genetic Disorders Market Other Major And Innovative Companies

• Biomarin Pharmaceutical Inc, Sarepta Therapeutics Inc., Krystal Biotech Inc., Rocket Pharmaceuticals Inc., Sangamo Therapeutics Inc., REGENXBIO Inc., Passage Bio Inc., Voyager Therapeutics Inc., Generation Bio Co., Avrobio Inc, Editas Medicine Inc., MeiraGTx Holdings Plc, uniQure N.V., Intellia Therapeutics Inc., Bluebird Bio Inc

38. Global Gene Therapy For Inherited Genetic Disorders Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Gene Therapy For Inherited Genetic Disorders Market

40. Gene Therapy For Inherited Genetic Disorders Market High Potential Countries, Segments and Strategies

• 40.1 Gene Therapy For Inherited Genetic Disorders Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Gene Therapy For Inherited Genetic Disorders Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Gene Therapy For Inherited Genetic Disorders Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer